MEDICOX Co. Ltd (054180) - Cash Flow Conversion Efficiency

Latest as of March 2025: -0.040x

Based on the latest financial reports, MEDICOX Co. Ltd (054180) has a cash flow conversion efficiency ratio of -0.040x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.26 Billion ≈ $-1.53 Million USD) by net assets (₩56.22 Billion ≈ $38.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of MEDICOX Co. Ltd for the company's overall valuation and market capitalisation.

MEDICOX Co. Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how MEDICOX Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

MEDICOX Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of MEDICOX Co. Ltd ranked by their cash flow conversion efficiency. Explore MEDICOX Co. Ltd earnings quality ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Oxbridge Re Holdings Equity Warrant NASDAQ:OXBRW	0.067x
Volvere PLC LSE:VLE	0.004x
PROMIS NEUROSCIENCES F:23J0	N/A
Nuvve Holding Corp NASDAQ:NVVE	4.065x
Ireka Corporation Bhd KLSE:8834	0.003x
IMMUTABLE HOLDINGS INC. F:B8X0	-0.142x
CML Microsystems Plc LSE:CML	0.030x
Aptorum Group Ltd Class A NASDAQ:APM	-0.039x

Annual Cash Flow Conversion Efficiency for MEDICOX Co. Ltd (2012–2024)

The table below shows the annual cash flow conversion efficiency of MEDICOX Co. Ltd from 2012 to 2024. View latest MEDICOX Co. Ltd stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩52.45 Billion ≈ $35.54 Million	₩-6.63 Billion ≈ $-4.50 Million	-0.126x	+11.47%
2023-12-31	₩62.24 Billion ≈ $42.18 Million	₩-8.89 Billion ≈ $-6.03 Million	-0.143x	+1.32%
2022-12-31	₩63.24 Billion ≈ $42.86 Million	₩-9.16 Billion ≈ $-6.20 Million	-0.145x	-32.31%
2021-12-31	₩66.20 Billion ≈ $44.87 Million	₩-7.24 Billion ≈ $-4.91 Million	-0.109x	+4.37%
2020-12-31	₩37.90 Billion ≈ $25.68 Million	₩-4.34 Billion ≈ $-2.94 Million	-0.114x	+23.98%
2019-12-31	₩21.17 Billion ≈ $14.34 Million	₩-3.19 Billion ≈ $-2.16 Million	-0.151x	-1297.78%
2018-12-31	₩21.22 Billion ≈ $14.38 Million	₩266.71 Million ≈ $180.74K	0.013x	+106.25%
2017-12-31	₩16.55 Billion ≈ $11.21 Million	₩-3.33 Billion ≈ $-2.25 Million	-0.201x	-835.66%
2016-12-31	₩19.11 Billion ≈ $12.95 Million	₩522.30 Million ≈ $353.96K	0.027x	-67.46%
2015-12-31	₩21.70 Billion ≈ $14.71 Million	₩1.82 Billion ≈ $1.23 Million	0.084x	+6.34%
2014-12-31	₩20.74 Billion ≈ $14.06 Million	₩1.64 Billion ≈ $1.11 Million	0.079x	+5.26%
2012-12-31	₩15.44 Billion ≈ $10.46 Million	₩1.16 Billion ≈ $785.10K	0.075x	--

About MEDICOX Co. Ltd

KQ:054180 Korea Aerospace & Defense

Market Cap

$573.12K

₩845.71 Million KRW

Market Cap Rank

#31005 Global

#2107 in Korea

Share Price

₩153.00

Change (1 day)

+0.00%

52-Week Range

₩153.00 - ₩153.00

All Time High

₩30388.84